Award
Delivery Order #SPE2DR26F7WM3
Short-Term Delivery Order Contract for Ondansetron HCL to Federal Agency
Buyer
Defense Logistics Agency
Award Amount
$848.62
Ceiling
$848.62
Awarded
March 11, 2026
Period of Performance
Mar 11, 2026 – Mar 12, 2026
Identifier
SPE2DR26F7WM3
NAICS
424210
This award represents a delivery order contract under an existing indefinite delivery vehicle (IDV) contract with AmerisourceBergen Drug Corp, a leading pharmaceutical distributor known for supplying essential medications. The contract is for the procurement of Ondansetron HCL 8 mg tablets, a drug commonly used to prevent nausea and vomiting caused by chemotherapy or surgery. This short-term, multi-day contract supports the agency's ongoing healthcare efforts by ensuring timely access to critical pharmaceuticals. The delivery order was competitively issued under the IDV framework, which was previously awarded for pharmaceutical product procurement, emphasizing efficient and reliable medication supply. The contract's limited duration and focused scope highlight its role in addressing specific, immediate treatment needs within the federal healthcare delivery system.
Description
4571117373!ONDANSETRON HCL 8 MG TABLET UD 100S